Стадии психоделического опыта от света до узоров | Владимир Алипов
Vladimir Alipov presents a structured breakdown of the stages of psychedelic experience, focusing on DMT and psilocybin. He describes the progression from enhanced sensory perception at the threshold level to geometric visual patterns at the 'chrysanthemum' stage, drawing connections between these phenomena and the fundamental architecture of the human brain.
Summary
The presentation by Vladimir Alipov outlines the staged nature of psychedelic experiences, particularly with DMT and psilocybin (psibin), moving through distinct perceptual levels.
The first level, described as the 'threshold level,' is characterized by enhanced color saturation and heightened attention to environmental detail. This stage is common with small doses or at the very onset of a psychedelic experience, and typically occurs within 3 to 30 seconds after inhaling DMT. Alipov cites a study indicating that 40% of people who used psilocybin reported a long-term improvement in their overall aesthetic experience — including a greater appreciation of nature, other people, and their surroundings — even after the effects wore off. He draws an analogy to the natural experience of stepping outside on a quiet summer evening at dusk, where the transition from noise and bright light to silence and dim lighting can produce a similarly heightened perceptual clarity.
The second level is called the 'chrysanthemum stage,' associated with doses around 4 to 8 mg of DMT. At this stage, geometric visual patterns begin to appear — initially simple Euclidean shapes like squares, rectangles, hexagons, and diamonds, which then evolve into more complex, hyperbolic spatial distortions. Alipov describes this as feeling like every point in space 'opens like a flower,' likening it to leaving the matrix and seeing reality at a deeper level. He also compares these visuals to old Windows screensavers.
Alipov offers a neuroscientific explanation for why these geometric patterns are seen: the repeating columnar structure of the visual cortex, when activated (whether by psychedelics, epileptic auras in the occipital lobe, or other stimulation), naturally generates repeating geometric patterns. This, he argues, explains why humans across cultures are drawn to ornaments, mandalas, kaleidoscopes, and decorative patterns — they reflect a fundamental structure of the brain rather than anything observed in the external natural world. He notes that this tendency is particularly pronounced in individuals with autistic traits.
Key Insights
- Alipov cites a study showing that 40% of people who took psilocybin reported a long-term improvement in their overall aesthetic experience — greater pleasure in observing nature, relationships, and surroundings — persisting after the drug's effects ended.
- Alipov argues that geometric visual patterns seen during psychedelic experiences are not random hallucinations but reflect the fundamental repeating columnar architecture of the visual cortex, which when stimulated naturally produces ornament-like imagery.
- At the 'chrysanthemum' stage of DMT use (around 4–8 mg), Alipov describes the experience as feeling like every point in space opens like a flower bud — as if one has 'left the matrix' and can perceive a deeper layer of reality.
- Alipov connects psychedelic geometric visuals to epileptic auras associated with the occipital lobes, suggesting both phenomena result from similar cortical activation patterns producing repeating geometric forms.
- Alipov notes that the enhanced perceptual clarity of the threshold level of psychedelic experience can be naturally approximated by stepping outside on a quiet summer evening at dusk, where sensory contrast sharpens perception in a comparable way.
Topics
Transcript
[0:00] So, that means the first level, the threshold level, yeah, that means you see what's happening, right? That is, at the first level this can be when taking a small dose or just at the very beginning. This is especially true for DMT, you see. So, you see, it usually happens between 3 and 30 seconds after a person has inhaled DMT. So what's going on with him? The first thing that appears in it is the color saturation, right? That is, this is what is happening, as if some kind of strengthening. Here is the enhancement. Here. And this also concerns [0:34] how he begins to perceive, as if noticing in more detail what you and I saw.…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Нейробиолог Владимир Алипов: лучшее
Картезианский театр и бесконечный гомункулус в голове | Владимир Алипов
The speaker explains the concept of the 'Cartesian Theater' — a philosophical metaphor originating with Descartes — where conscious experience arises when unconscious brain processes 'step onto a stage' observed by an inner homunculus. He then critiques the infinite regress problem this creates (who observes the observer?) and connects it to Baars' Global Workspace Theory, which offers a similar theatrical metaphor but without requiring a homunculus audience.
Почему мозг устает и падает концентрация | Владимир Алипов
Vladimir Alipov answers viewer questions about brain fatigue during concentration, flat feet and exercise recommendations, and the health risks associated with tall stature. He explains that mental fatigue is likely caused by glucose depletion in neurons, and that skill automation frees up working memory over time.
Как измеряют психоделический опыт: шкалы, эффекты | Владимир Алипов
Vladimir Alipov discusses scientific scales used to measure psychedelic experiences, covering perceptual phenomena like synesthesia, depersonalization, and time distortion. He explains the concept of 'set and setting' as key determinants of whether a psychedelic experience is positive or negative. He also briefly addresses non-pharmacological alternatives for achieving transcendental states.
Психоделики и шизофрения: мифы, риски, факты | Владимир Алипов
Vladimir Alipov discusses the historical misconception that psychedelics are 'psychotomimetics' that cause psychosis, examining the actual risks of psychedelics in relation to schizophrenia. He argues that while psychedelics rarely cause psychosis in healthy individuals, people with a hereditary predisposition to schizophrenia may be at elevated risk, and that research was largely halted due to political stigma in the US.
Психоделики без зависимости, но синтетика убивает | Владимир Алипов
Vladimir Alipov discusses the safety profile of natural and semi-synthetic psychedelics, noting they do not cause addiction or fatal overdoses based on research and large-scale use among hippies. He contrasts this with synthetic psychedelics, which carry serious risks including death, citing a real case of a fatal outcome from a synthetic compound called Bromo-Dragonfly.